Daniel Truhn1, Christiane K Kuhl2, Alexander Ciritsis2, Alexandra Barabasch2, Nils A Kraemer2. 1. Department of Diagnostic and Interventional Radiology, RWTH University Hospital Aachen, Pauwelsstraße 30, 52074, Aachen, Germany. dtruhn@ukaachen.de. 2. Department of Diagnostic and Interventional Radiology, RWTH University Hospital Aachen, Pauwelsstraße 30, 52074, Aachen, Germany.
Abstract
OBJECTIVES: Most existing models that are in use to model hepatic function through assessment of hepatic gadoxetic acid enhancement kinetics do not consider quantitative measures of gadoxetic excretion. We developed a model that allows a simultaneous quantitation of uptake and excretion of liver specific contrast agents. The aim was to improve the assessment of hepatic synthetic function, and provide quantitative measures of hepatic excretion function. METHODS: Sixteen patients underwent dynamic T1-weighted turbo gradient echo imaging at 1.5 T prior and after bolus injection of gadoxetic acid at 0.1 ml/kg. DCE-images were obtained for 30 min after injection. A dual-inlet two-compartment model was then used to fit the measured liver signal values. Four tissue parameters (extracellular volume fraction, arterial flow fraction, uptake rate and excretion half-time) were extracted for each liver segment. RESULTS: The proposed model provided a good fit to acquired data. Mean values for arterial flow fraction (0.08+-0.04), extracellular volume (0.20±0.08) and uptake rate (4.02 ±1.32 /100 ml/min) were comparable to those obtained with the conventional model (0.08±0.05, 0.21±0.12, and 4.93±1.74), but exhibited significantly less variation and improved fit quality. CONCLUSIONS: The proposed model is more accurate than existing conventional models and provides an additional excretion parameter. KEY POINTS: • Models of hepatic contrast agent uptake can be extended to include excretion. • Including an additional excretion parameter improves accuracy of the model. • Standard diagnostic sequences can be extended to incorporate the model.
OBJECTIVES: Most existing models that are in use to model hepatic function through assessment of hepatic gadoxetic acid enhancement kinetics do not consider quantitative measures of gadoxetic excretion. We developed a model that allows a simultaneous quantitation of uptake and excretion of liver specific contrast agents. The aim was to improve the assessment of hepatic synthetic function, and provide quantitative measures of hepatic excretion function. METHODS: Sixteen patients underwent dynamic T1-weighted turbo gradient echo imaging at 1.5 T prior and after bolus injection of gadoxetic acid at 0.1 ml/kg. DCE-images were obtained for 30 min after injection. A dual-inlet two-compartment model was then used to fit the measured liver signal values. Four tissue parameters (extracellular volume fraction, arterial flow fraction, uptake rate and excretion half-time) were extracted for each liver segment. RESULTS: The proposed model provided a good fit to acquired data. Mean values for arterial flow fraction (0.08+-0.04), extracellular volume (0.20±0.08) and uptake rate (4.02 ±1.32 /100 ml/min) were comparable to those obtained with the conventional model (0.08±0.05, 0.21±0.12, and 4.93±1.74), but exhibited significantly less variation and improved fit quality. CONCLUSIONS: The proposed model is more accurate than existing conventional models and provides an additional excretion parameter. KEY POINTS: • Models of hepatic contrast agent uptake can be extended to include excretion. • Including an additional excretion parameter improves accuracy of the model. • Standard diagnostic sequences can be extended to incorporate the model.
Entities:
Keywords:
Contrast media; Hepatobiliary elimination; Magnetic resonance imaging; Patient-specific modelling
Authors: Martin Rohrer; Hans Bauer; Jan Mintorovitch; Martin Requardt; Hanns-Joachim Weinmann Journal: Invest Radiol Date: 2005-11 Impact factor: 6.016
Authors: Hyeonjin Kim; Sara E Taksali; Sylvie Dufour; Douglas Befroy; T Robin Goodman; Kitt Falk Petersen; Gerald I Shulman; Sonia Caprio; R Todd Constable Journal: Magn Reson Med Date: 2008-03 Impact factor: 4.668
Authors: O Dahlqvist Leinhard; N Dahlström; J Kihlberg; P Sandström; T B Brismar; O Smedby; P Lundberg Journal: Eur Radiol Date: 2011-10-09 Impact factor: 5.315
Authors: Andreas Wibmer; Qayyum Aliya; Rudolf Steininger; Michael Trauner; Judith Maresch; Ferdinand Mühlbacher; Ahmed Ba-Ssalamah Journal: Invest Radiol Date: 2012-06 Impact factor: 6.016
Authors: Martin Stockmann; Johan F Lock; Maciej Malinowski; Stefan M Niehues; Daniel Seehofer; Peter Neuhaus Journal: HPB (Oxford) Date: 2010-03 Impact factor: 3.647
Authors: F Rassam; T Zhang; K P Cieslak; C Lavini; J Stoker; R J Bennink; T M van Gulik; L J van Vliet; J H Runge; F M Vos Journal: Eur Radiol Date: 2019-02-22 Impact factor: 5.315
Authors: Johannes Thüring; Oliver Rippel; Christoph Haarburger; Dorit Merhof; Philipp Schad; Philipp Bruners; Christiane K Kuhl; Daniel Truhn Journal: Eur Radiol Exp Date: 2020-04-06